Meet an Unreasonable Venture
ArkeaBio
Developing a safe, cost-effective methane reducing vaccine to lower emissions from cattle worldwide
ArkeaBio is developing a next-generation livestock vaccine to reduce methane emissions from ruminants. The vaccine targets methanogenic archaea in the rumen, disrupting methane production at its microbial source. Backed by Breakthrough Energy Ventures and The Grantham Foundation, ArkeaBio is conducting vaccine development and field trials in the U.S. at Texas A&M. Long-term, it aims to provide a scalable, affordable, and safe solution to decarbonize the global livestock sector.
Notable Achievements
- First company to demonstrate a vaccine to reduce methane emissions in cattle.
- Built an experienced team of biotech professionals, most with start-up experience.
- Developing methane mitigation solution for all 1.5 billion cattle worldwide.
Currently Operating in 135 Regions
Get the Unreasonable Newsletter
Get monthly updates on ArkeaBio and all of the other ventures working to solve global challenges.